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Abstract
Background: Through several initiatives, there are increasingly more people who have access to anti-retroviral therapy. Adher-
ence to therapy is, however,necessary for successful management of  disease.
Objectives: The objectives of  this study were to describe adherence rates and determine what patient-related factors are related 
to adherence to anti-retroviral therapy among adult patients in an HIV clinic located in Lagos, Nigeria.
Methods: Adherence was measured using the two-week self-recall method. Barriers, satisfaction with therapy, and socio-demo-
graphic and clinical variables served as independent variables. Data were collected via self-administered surveys.
Results: . Most of  the patients (79.5%) reported 100% adherence. The significant (p<0.05) barriers to adherence were forget-
fulness, running out of  medication, alcohol use, and medication side effects. For every unit increase in the number of  barriers, 
patients were 60.8% less likely to be 100% adherent (p <0.05, odds ratio, OR = 0.392,95% CI = 0.295-0.523). 
Conclusion: Interventions should target helping patients cope with forgetfulness, specifically employing strategies to overcome 
busyness in schedules, being away from home, and tiredness.
Keywords: Medication adherence, patients, anti-retroviral therapy.
DOI: https://dx.doi.org/10.4314/ahs.v17i3.16
Cite as: Nduaguba SO, Soremekun RO, Olugbake OA, Barner JC. The relationship between patient-related factors and medication adherence 
among nigerian patients taking highly active anti-retroviral therapy. Afri Health Sci. 2017;17(3): 738-745. https://dx.doi.org/10.4314/ahs.
v17i3.16
Introduction
Adherence, which has been defined by the World Health 
Organization as the “extent to which a person’s be-
haviour corresponds with agreed recommendations from 
a health care provider”1, is all encompassing ranging 
from following recommendations on how to use a med-
ication to adjusting one’s behaviour and making lifestyle 
changes. Medication recommendations include the dos-
ing frequency, how long to use the medication, dietary 
restrictions and other medications to avoid. It is usually 
expected that if  a drug is used according to recommenda-
tions, optimal benefits of  cure, prevention, or control of  
disease will occur. Anti-retroviral agents, which are used 
in the management of  Human Immunodeficiency Virus 
(HIV) infection, do not have the capacity to totally elim-
inate the virus from an infected individual but will help 
in achieving virological control if  the patient is adherent. 
Besides achieving virological control, antiretroviral drugs 
enhance diminished immune function and limit the de-
velopment of  resistant strains of  the virus.2 Successful 
medication management of  the infection involves taking 
medication for life with at as high as 95% adherence for 
virological control.3
More than 36 million people are living with HIV globally, 
with 1.1 million people dying from AIDS-related causes 
in 2015.4 Although the incidence of  HIV is declining and 
more people are gaining access to antiretroviral medica-
tion5, the benefits of  medication cannot be derived unless 
patients take their medication. Globally, adherence to an-
tiretroviral agents varies between 37% and 83%.1
Adherence is a continuous and dynamic process espe-
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cially in drug therapy of  chronic illnesses such as HIV/
AIDS and as such patients have to be closely followed.1 
The consequences of  poor adherence to long-term thera-
pies include a reduction in the effectiveness of  treatment. 
For HIV/AIDS, this involves the development of  drug 
resistance, increased risk of  transmission of  drug resis-
tance to other infected individuals during high risk activ-
ity, treatment failure (increased viral load and decreased 
CD4+ count), disease progression, and death. Because 
treatment failure is closely associated with non-adher-
ence, factors affecting adherence must be continually as-
sessed and addressed.6
The World Health Organization has identified five sets 
of  factors that affect patients’ adherence to therapy: 
socio-economic, health care team and system-related, 
condition-related, therapy-related, and patient-related 
factors. These sets of  factors including health care team 
and system-related factors, are mostly dependent on pa-
tient characteristics and experiences. For example, a good 
patient-provider relationship can improve adherence.1 
In particular, patients’satisfaction with therapy has been 
linked to adherence.7 Since, it encompasses patients’ ex-
perience with the health-care system, it deserves special 
attention. Because adherence depends on active partic-
ipation of  the patient, it is necessary that interventions 
designed for patient populations are mostly relevant for 
the individual patients.
In Nigeria and other parts of  Africa, several studies as-
sessing factors affecting adherence have been conduct-
ed.8-17 Among the studies measuring adherence by self-re-
port, the proportion of  ART-adherent patients range 
from 63% to 88% for optimal adherence and 15% to 
73% for full adherence. Charurat and colleagues mea-
sured adherence using pharmacy refill rates and found 
only 26% of  the patients in their study to be optimally ad-
herent.12 These studies found age, gender, marital status, 
educational status, personal beliefs about health, traveling 
distance, duration of  time on antiretroviral therapy, CD4 
count, forgetfulness, and willingness to disclose status to 
be associated with adherence. While a lot of  attention has 
been given to patient characteristics and other patient-re-
ported barriers to adherence, little attention has been giv-
en to patient satisfaction as a potential factor affecting 
adherence. The objectives of  this study were to describe 
adherence rates and to determine which patient-related 
factors (sociodemographic, clinical, adherence-related 
barriers, and/or satisfaction with medication) are related 
to adherence to therapy among patients living with HIV 
(PLWH) receiving ART in a treatment center in Lagos, 
Nigeria.
Methods
This study was a cross-sectional survey conducted in the 
AIDS Prevention Initiative of  Nigeria (APIN) clinic of  
the Lagos University Teaching Hospital, a tertiary center 
in Lagos, Nigeria. This clinic has been operating since 
2007 and is open from 8am to 4pm on weekdays, ex-
cluding holidays. It provides Highly Active Antiretroviral 
Therapy (HAART) free of  charge to patients. For acutely 
ill patients, nurses and peer support patients are available 
for home visits and medication delivery. As of  2012, the 
clinic had at least 6,000 patients of  varying socioeconom-
ic status who were registered and receiving HAART, typi-
cally living between 100m and 1km. Patients receive refills 
on a monthly basis. Those included in this study were a 
convenient sample of  patients living with HIV/AIDS, 18 
years or older, receiving HAART, and had visited the clin-
ic between June and July 2012. Proxies who were picking 
up medications for a patient were excluded. The study 
was approved by the Research and Ethics Committee of  
the College of  Medicine at the University of  Lagos.
In this study, the main dependent variable was self-re-
ported adherence which was operationalized as the per-
centage of  doses a patient actually took relative to the 
number of  doses required within the past two weeks.9 
This is mathematically represented as:
Required number of  doses per day X 14 - Number of  
doses missed  X 100%
Required number of  doses per day X 14
Using the above formula, patients were categorized as 
fully adherent (100% adherent) or not fully adherent (< 
100% adherent) and as optimally adherent (≥95% adher-
ent) or not optimally adherent (< 95% adherent).
Patients were asked about barriers to adherence using an 
eight-item (side effects, forgetting, improvement in health, 
fear of  stigma, running out of  medication, alcohol, pill 
burden, and decline in health) scale introduced with the 
question, ’Have any of  the following prevented you from 
taking your medication?’ and with ‘yes’ and ‘no’ as pos-
sible responses. Six of  the items (side-effects, forgetting, 
fear of  stigma, running out of  medication, alcohol, and 
pill burden) were derived from studies conducted in Ni-
geria that assessed barriers to adherence.18 The remaining 
2 items were derived from the World Health Organiza-
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tion’s document on adherence to long-term therapies.1 
The number of  items that each patient answered ‘yes’ to 
was summed to create total number of  barriers. Satisfac-
tion with therapy was measured with three items on a 
five-point Likert scale ranging from 1 (very dissatisfied) 
to 5 (very satisfied). The questions asked were ‘How cer-
tain are you that the good things about your medication 
outweigh the bad things?’, ‘How satisfied or dissatisfied 
are you with this medication?’ and ‘Taking all things into 
account, how satisfied are you about being able to cope 
with side effects?’.  Lastly, socio-demographic (age, gen-
der, marital status, educational status, and occupational 
status) and clinical (length of  time since diagnosis and 
length of  time since commencing HAART) data were 
collected.
Data were collected every work day for a period of  one 
month because the majority of  patients returned to the 
clinic monthly to receive their free HAART therapy. Pa-
tients in the clinic were approached by a researcher and 
invited to voluntarily participate in the study. Those who 
agreed were given a packet containing a cover letter, a 
consent form, and the survey. Those who participated in 
the study returned a signed consent form and completed 
survey. The survey instrument was self-administered in 
English and it took approximately 20 minutes to com-
plete. A required sample size of  361 was obtained us-
ing Cochran’s sample size formula for categorical data.19 
Thus data were collected until usable responses reached 
that number.
Descriptive statistics (frequencies and means) were used 
to characterize the study variables. Pearson’s chi-square(di-
chotomous data) and analysis of  variance (continuous 
data) were used to examine bivariate relationships with 
adherence and socio-demographic and clinical variables, 
barriers, and satisfaction. Fisher’s exact test (dichotomous 
data) was employed in place of  chi-square analysis where 
less than 80% of  the cells had expected counts more than 
5. Logistic regression was used to determine what fac-
tors (age, gender, marital status, educational status, oc-
cupational status, length of  time since diagnosis, length 
of  time since commencing HARRT, number of  barriers, 
and/or patient satisfaction) were related to medication 
adherence. Missing values were handled using case-wise 
deletion. The statistical package, SAS 9.4, was used for 




To achieve the required sample size of  361, more sur-
veys (384) were collected as some of  them were unusable 
as a result of  incomplete responses. Table 1 shows the 
majority of  the study sample were between 18 and 40 
years (64.9%), female (58.3%), married (64.8%), working 
(83.8%), and on HAART for at least one year (82.0%) 
while a plurality of  the sample had a college education 
(46.5%). The vast majority of  patients were satisfied 
(84.8%) with their medication (mean satisfaction score 
= 4.1±0.8). Additionally, most of  the patients (83.3%) 
had 0 or 1 barrier with mean number of  barriers equal 
to 0.8±1.0. Based on the two-week self-recall, mean ad-
herence was 99.1%±3.1% and ranged between 75% and 
100%. The majority (79.5%) were fully (100%) adherent 
while a larger proportion (92.9%) were optimally (≥ 95%) 
adherent.
Table 1 shows cross-tabulations between patient de-
mographic profile, length of  time since commencing 
HAART, and satisfaction profile with absolute adher-
ence. None of  the factors (age, gender, marital status, ed-
ucational status, occupational status, length of  time since 
commencing HAART, and satisfaction with therapy) 
were associated with 100% adherence. 
African Health Sciences Vol 17 Issue 3, September, 2017740











N % N % N % 
AGEb 
11-30 years 64 22.6 13 17.8 77 21.6   
  
0.543 
31-40 years 117 41.3 37 50.7 154 43.3 
41-50 years 74 26.2 17 23.3 91 25.6 
>50 years 28 9.9 6 8.2 34 9.6 
Total 283 100.0 73 100.0 356 100.0 
GENDERb 
Male 122 42.5 28 38.4 150 41.7   
.413 Female 165 57.5 45 61.6 210 58.3 
Total 287 100.0 73 100.0 360 100.0 
MARITAL STATUS 
Not married 106 36.9 21 28.4 127 35.2   
1.888 Married 181 63.1 53 71.6 234 64.8 
Total 287 100.0 74 100.0 361 100.0 
EDUCATIONAL STATUSb 
No college education 153 54.1 38 51.4 166 53.5   
.173 College education 130 45.9 36 48.6 191 46.5 
Total 283 100.0 74 100.0 357 100.0 
OCCUPATIONAL STATUSb 
Not working 48 16.9 10 13.5 58 16.2   
.496 Working 236 83.1 64 86.5 300 83.8 
Total 284 100.0 74 100.0 358 100.0 
LENGTH OF TIME SINCE DIAGNOSIS 
<1 year 39 13.6 10 13.5 49 13.6   
  
3.082 
1-<3 years 86 30.0 19 25.7 105 29.1 
3-<5 years 87 30.3 30 40.5 117 32.4 
≥5 years 75 26.1 15 20.3 90 24.9 
Total 287 100.0 74 100.0 361 100.0 
LENGTH OF TIME SINCE COMMENCING HAART 
<1 year 54 18.8 11 14.9 65 18.0   
  
4.050 
1-<3 years 95 33.1 23 31.1 118 32.7 
3-<5 years 76 26.5 28 37.8 104 28.8 
≥5 years 62 21.6 12 16.2 74 20.5 
Total 287 100.0 74 100.0 361 100.0 
SATISFACTION LEVEL 
Dissatisfied 11 3.8 8 10.8 19 5.3   
5.956 Neither satisfied nor 
dissatisfied 
28 9.8 8 10.8 36 10.0 
Satisfied 248 86.4 58 78.4 306 84.8 
Total 287 100.0 74 100.0 361 100.1c 
Table 1: Crosstabulation of patient demographic profile, clinical profile, and satisfaction with therapy 
and 100% adherencea 
aAdherence was as determined by the 2-week self recall method 
bThere were missing values for the factor 
cDid not sum to 100.0 due to rounding 
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aData were available for 360 patients. Adherence was as determined by the 2-week recall method 
bSignificant at p<0.05 
cFisher’s exact test 
Table 2 shows the reasons provided by patients for miss-
ing doses. Forgetting was the main reason patients missed 
doses. Among patients who admitted to forgetting to take 
their medication, 15.3%, 15.3%, and 9.9% respectively 
reported being busy, being away from home, and being 
tired as reasons for forgetting to take their medication.
The overall logistic regression model was significant 
(Likelihood ratio: 2 = 65.43, p < 0.05) with number of  
barriers and satisfaction level being significantly associat-
ed with 100% adherence (Wald: 2 = 40.22 and 6.82, re-
spectively; p < 0.05). For every unit increase in the num-
ber of  barriers, patients were 54.8% less likely to be 100% 
adherent (p < 0.05, odds ratio, OR = 0.452, 95% CI = 
0.353-0.578). Patients who were dissatisfied with therapy 
were 66.9% less likely to be 100% adherent, compared 
to those who were satisfied (p < 0.05, OR = 0.331, 95% 
CI = 0.110-0.996). There was no significant difference 
between patients who were satisfied and those who were 
neither satisfied nor dissatisfied. Because number of  bar-
riers was associated with adherence, a post-hoc analysis 
(Pearson’s chi-square test) was conducted to determine 
which specific barriers were associated with 100% adher-
ence (Table 2). Forgetting, running out of  medication, 
use of  alcohol, and side effects were significantly associ-
ated with less than 100% adherence.
Table 2: Cross-tabulation of barriers to adherence and 100% adherence (N=361)a 
 
BARRIERS 100% Adherent (N=287) Not 100% Adherent 
(N=73) 
Total               (N=360) ᵪ2 
N % N % N % 
FORGETTING 
  Yes 68 18.9 62 17.2 130 36.1 94.598b 
  No 219 60.8 11 3.1 230 63.9 
RUNNING OUT OF MEDICATION 
  Yes 22 6.1 15 4.2 37 10.3 10.474b 
  No 265 73.6 58 16.1 323 89.7 
IMPROVEMENT IN HEALTH 
  Yes 24 6.7 10 2.8 34 9.4 1.938 
  No 263 73.1 63 17.5 326 90.6 
ALCOHOL 
  Yes 14 3.9 10 2.8 24 6.7 7.277b 
  No 273 75.8 63 17.5 336 93.3 
 SIDE EFFECTS 
  Yes 12 3.3 9 2.5 21 5.8 7.033b 
  No 275 76.4 64 17.8 339 94.2 
WORSENING HEALTH 
  Yes 8 2.2 3 0.8 11 3.1 8c 
  No 279 77.5 70 19.4 349 96.9 
PILL BURDEN 
  Yes 7 1.9 3 0.8 10 2.8 7c 
  No 280 77.8 70 19.4 350 97.2 
FEAR OF STIGMA 
  Yes 5 1.4 4 1.1 9 2.5 5c 
  No 282 78.3 69 19.2 351 97.5 
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Discussion
This study was conducted to determine HAART med-
ication adherence rate, barriers to adherence, and the 
relationship between age, gender, marital status, educa-
tional status, occupational status, and length of  time since 
commencing HAART, barriers, and satisfaction and ad-
herence. The results indicated that most (92.9%) patients 
were optimally adherent (i.e., ≥ 95%). A contributing fac-
tor to this high rate of  adherence may be the setting in 
which data was collected. Respondents in this study came 
from a pool of  patients who had come to the clinic for 
prescription refills. This pool are more likely to be more 
adherent than patients who were missing refill appoint-
ments. Such high rates of  adherence (88% to 94%) have 
been observed in other populations within Nigeria and 
other parts of  Africa.13,14,17 However, some studies using 
patient self-report have recorded optimal adherence rates 
as low as 63%.9 The goal in counselling is usually to en-
courage the patient to take medication according to direc-
tions. Hence, although most patients are optimally adher-
ent (≥ 95% adherence), interventions aimed at bringing 
other patients to maximally possible adherence levels are 
still necessary.
Number of  barriers and patient satisfaction were found 
to be significantly associated with medication adherence. 
Of  the barriers investigated, forgetting, running out of  
medication, alcohol, and side effects were predictors of  
adherence. As has been found in other studies, forgetting 
was the major reason for missing doses in this study.14,20-22 
This information is important for determining which in-
terventions will work for this population of  patients as 
increasing the effectiveness of  adherence interventions 
may have a far greater impact on the health of  the popu-
lation than improvements in specific medical treatments.1 
In this study, when patients were asked specifically why 
they forget to take their medication,fifteen percent re-
ported that it was because of  their busy schedule. This 
might be an indication that some patients see taking their 
medication as an added burden to their daily activities. 
This finding is comparable to the study in which some 
patients regarded the use of  anti-retroviral medications 
as a burden.23 Helping patients integrate and incorporate 
medication taking behaviours in their daily routines may 
assist them in taking better control of  their health and 
improve medication uptake. Studies show that the use of  
the pill box and medication reminder systems improve 
adherence.15,24 These are relatively in expensive methods 
for improving patients’ organizational skills.
Running out of  medication was another reason for miss-
ing doses. It may mean that patients are missing refill ap-
pointments at the clinic. Medications are free for patients 
at the clinic. So, investigation is needed to determine 
whether cost of  transportation, clinic hours, or some 
other reason is responsible. Also, health care counselors 
need to emphasize the implications of  poor adherence, 
how alcohol use affects adherence, how to manage side 
effects, as well as stress the lifelong need for adherence. 
In particular, patients can be encouraged to utilize their 
social network as high level of  social support has been 
found to be associated with better adherence.25,26
In our study, satisfaction with therapy was found to be 
associated with medication adherence. Other studies have 
found adherence to be associated with satisfaction with 
different health system components including informa-
tion received from providers15 and services provided.27 
Based on this, we recommend that periodic feedback be 
sought from patients and used to tailor care to individual 
needs and expectations. This may improve patient expe-
rience with the health care system and ultimately satisfac-
tion and adherence to recommendations.
Patients were selected using convenience sampling and 
participation was based on their willingness. As  a result, 
patients who completed the questionnaire may have been 
systematically different from those who did not, even 
though data collection was designed to reach all patients 
over the course of  one month. We believe that patient 
English literacy may have contributed to selection bias 
because the questionnaire was administered in English 
and those with little formal education may have been less 
willing to participate in the study. This may explain why 
almost half  of  our respondents had college education. 
To minimize this limitation, the researcher offered to ad-
minister the questionnaire while interviewing those who 
mentioned that they could not read in English. Adher-
ence using the two-week recall method may have been 
over-reported due to the need for social desirability by 
the patients since data was collected at the clinic and re-
searchers were also present during data collection. Pa-
tients were, however, reassured that the survey was for 
research purposes. Also, because adherence was so high, 
cross-tabulation of  adherence and some demographic 
and clinical variables resulted in small cell sizes, which 
could make some statistical analyses invalid. To increase 
the statistical validity of  results, some cross-tabulation 
cells were merged and Fisher’s exact test was used in place 
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of  chi-square test where less than 80% of  the cells had 
expected cell size less than 5. In addition, while our scale 
on barriers to adherence was based on a review of  the 
literature, there may have been other barriers that we did 
not capture. Finally, we had a relatively small sample size 
for our logistic regression (8 events per covariate). Al-
though some studies indicate that there may be some bias 
in the regression coefficients, other studies suggest that 
between 5 and 9 events per covariate, bias is common and 
where it occurs, it is within acceptable levels.28,29 However, 
we still recommend caution in interpreting the results of  
our study.
In summary, adherence rate among the patients studied 
at this clinic in Lagos, Nigeria  was high. Since having a 
busy lifestyle may pose a challenge towards patients re-
membering to take their medication, the use of  the pill 
box, reminder systems, and social support may help im-
prove patients’ organizational skills and integrate medica-
tion-taking behavior into patients’ lifestyle. Tailoring pa-
tient care based on patient feedback may improve patient 
satisfaction with therapy and hence, adherence.  
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